Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Has Accepted For Filing The First Potential Once-a-Day Nasal Antihistamine
Medical News Today
Sunday, October 26, 2008 - 12:29pm
tags:
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
MarketWatch
Sunday, October 26, 2008 - 12:26pm
tags:
Dental Co-op Seeks to Revolutionize Healthcare
Fox 12 Boise, ID
Sunday, October 26, 2008 - 12:24pm
tags:
New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
The Earth Times
Sunday, October 26, 2008 - 12:23pm
tags:
Targanta Therapeutics Presents In Vitro Data Highlighting Oritavancin's Potent Activity Against Gram-Positive Pathogens
Genetic Engineering and Biotechnology News
Saturday, October 25, 2008 - 12:58pm
tags:
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New U.S. Observational Study
International Business Times
Saturday, October 25, 2008 - 12:56pm
tags:
DUSA Announces Results For Phase IIB Trial Of Levulan® Photodynamic Therapy For Moderate To Severe Acne
Bioresearch Online
Saturday, October 25, 2008 - 12:54pm
tags:
Sun Pharma Q2 net up 2-fold at Rs 513 cr
ZeeNews, India
Saturday, October 25, 2008 - 12:52pm
tags:
Biotie to acquire CNS and inflammation specialist elbion GmbH
PR-Canada, Canada
Saturday, October 25, 2008 - 12:49pm
tags:
Pfizer declares regular dividend of 32 cents
Yahoo/AP
Saturday, October 25, 2008 - 12:47pm
tags:
Acusphere Announces Signing of a Definitive Agreement with Cephalon
International Business Times
Saturday, October 25, 2008 - 12:42pm
tags:
Calando Pharmaceuticals completes Phase I cancer trial
Pharmaceutical Business Review
Saturday, October 25, 2008 - 12:41pm
tags:
GSK Pays Affiris $28M Up Front in Alzheimer's Vaccine Deal
Bioworld
Saturday, October 25, 2008 - 12:23pm
tags:
Tempo Pharmacueticals changes its name
San Antonio Business Journal, TX
Saturday, October 25, 2008 - 12:21pm
tags:
Astellas Pharma Withdraws Europe Application For Antibiotic
Alibaba News Channel
Saturday, October 25, 2008 - 12:20pm
tags:
Pfizer to Pay $60 Million to Settle With States Over Promotion of Painkiller
New York Times
Saturday, October 25, 2008 - 12:19pm
tags:
Affymetrix Has Trouble Turning Around
Motley Fool
Saturday, October 25, 2008 - 12:16pm
tags:
Lilly's Results Run the Gamut
Motley Fool
Saturday, October 25, 2008 - 12:16pm
tags:
Heska Announces Receipt of Letter from Nasdaq
Yahoo
Saturday, October 25, 2008 - 12:15pm
tags:
VioQuest Pharmaceuticals Provides Strategic Alternatives Review and Operations Update
Yahoo
Saturday, October 25, 2008 - 12:14pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.